Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2013.01.21
关于持股5%以上股东减持股份的提醒性通告
2013.01.21
简式权益变换报告书(已作废)
2013.01.11
关于对外投资希望的通告
2013.01.09
关于竞得土地使用权的通告
2012.12.28
关于拟使用部分超募资金加入竞买土地使用权的通告
2012.12.28
中国中投证券有限责任公司关于公司部分超募资金使用有关事项的保荐意见
2012.12.28
关于使用部分超募资金受让控股子公司部分股权并对其举行增资的通告
2012.12.28
第二届监事会第二十次聚会决议通告
2012.12.28
第二届董事会第二十二次聚会决议通告
2012.12.13
2012年第三次暂时股东大会决议通告
第一页
上一页
123
124
125
126
127
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】